Jk. Wamsley et al., INTERACTION OF FELBAMATE WITH [H-3] DCKA-LABELED STRYCHNINE-INSENSITIVE GLYCINE RECEPTORS IN HUMAN POSTMORTEM BRAIN, Experimental neurology, 129(2), 1994, pp. 244-250
The dicarbamate felbamate has been shown to be capable of competing fo
r the binding of 5,7-[H-3]dichlorokynurenic acid ([H-3]DCKA) to strych
nine-insensitive glycine receptors in sections of human postmortem bra
in. The IC50 for this interaction was 305.8 mu M and the inhibition wa
s complete at 1 mM. Autoradiographic localization of [H-3]DCKA binding
revealed many regions of human brain in which strychnine-insensitive
glycine receptors are manifest. The specific binding in most of these
areas was markedly reduced in the presence of 625 mu M felbamate. In m
any regions, [H-3]DCKA binding was reduced to background in the presen
ce of felbamate, but some areas retained binding by as much as 41% (i.
e., the CA2 region of the hippocampus). This is in contrast to the bin
ding of [H-3]DCKA in the presence of carbamazepine, phenytoin, or valp
roic acid. The binding of the glycine receptor antagonist was not affe
cted by any of these latter agents to the same degree as felbamate. St
rychnine-insensitive glycine receptors represent a site of action of f
elbamate in the human brain. (C) 1994 Academic Press, Inc.